Omega TherapeuticsOMGAQ
13F holders, Q1 2025 (March 31)4holders −49
0new positions
49sold out
$0.13avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Omega Therapeutics Inc. (OMGAQ) in their 13F filings, down 49 from Q4 2024. 0 opened new positions and 49 sold out. The largest holders were Barclays PLC ($1K), Principal Securities, Inc. ($1K) and Steward Partners Investment Advisory, LLC ($405).
- Company
- Omega Therapeutics Inc.
- CUSIP
- 68217N105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 49 | $35.2M |
All 13F filers, Q4 2024 → Q1 2025: 47,262,458 shares sold, net −47,262,458 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Barclays PLC | 0.00% | No change | 13,278 | $1K |
| Principal Securities, Inc. | 0.00% | No change | 1,370 | $1K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 5,000 | $405 |
| Huntington National Bank | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is OMGAQ's weight in each manager's 13F, not the share of Omega Therapeutics Inc. the manager owns.